Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Bullboard Posts
Comment by CryptoCapon Sep 12, 2020 12:01am
288 Views
Post# 31547866

RE:RE:RE:RE:RE:Expecting THRM to run 5 dollars sometime this year

RE:RE:RE:RE:RE:Expecting THRM to run 5 dollars sometime this year
Yes...$5 would be 30x-35x SP right now and a market cap of 900m...That is just outrageous for a test that likely wont be commercialized IF it is successfully developed in the 1Q of next year.

I think a conservative estimate of fantastical projections is capped at $3 and if that only briefly. $1-2 would be a huge success for most investors. The climb to the previous high is the most arduous however. Many steps to take from both the company and larger investors to make the a possibility.
Bullboard Posts